Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 19;3(7):000451.
doi: 10.12890/2016_000451. eCollection 2016.

Acute Cardiac Tamponade in a 77-year-old Italian Woman with Erdheim-Chester Disease

Affiliations

Acute Cardiac Tamponade in a 77-year-old Italian Woman with Erdheim-Chester Disease

Maria Kyriakopoulou et al. Eur J Case Rep Intern Med. .

Abstract

Erdheim-Chester disease (ECD) is a non-Langerhans' histiocytosisand a veryrare multisystemic disease of unknown aetiology, with skeletal involvement of the long bones and in more than 50% of cases with extraskeletal involvement. The disease was described in 1930 by the anatomopathologist Jakob Erdheim and his student William Chester. More than 500 cases have since been reported. We report the case of a 77-year-old Italian woman with ECD who was admitted to hospital for acute cardiac tamponade. The patient presented with simultaneous cutaneous, retro-orbital, skeletal, cerebral and cardiovascular manifestations and was successfully treated with corticosteroids followed by interferon.

Learning points: Erdheim-Chester disease (ECD) is a non-Langerhans' histiocytosisand a very rare multisystemic disease that is thought to be associated with cytokine disturbances.ECD has a variable prognosis but is poorer in those with heart involvement.First-line treatment involves the administration of interferon alpha.

Keywords: BRAF; Erdheim-Chester disease; interferon alpha; tamponade.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interests.

Figures

Figure 1
Figure 1
Bilateral exophthalmos and xanthogranuloma
Figure 2
Figure 2
Cardiac echography (PE, pericardial effusion; RA, right atrium; RV, right ventricle)
Figure 3
Figure 3
Chest radiogram showing cardiomegaly and mild bilateral pleural effusion
Figure 4
Figure 4
PET CT howing orbital, humeral, radial, trochanteric, femoral, colic and pleural FDG uptake and FDG uptake by the thoracic aorta, the pericardium, the right atrioventricular orifice and the left breast
Figure 5
Figure 5
Cardiac MRI showing pericardial thickening associated with delayed enhancement, delayed enhancement at the atrioventricular orifices, and circumferential non-transmural enhancement of the thoracic aortic wall (at the adventitia, sparing the muscular layer)

Similar articles

Cited by

References

    1. Mazor RD, Manevich-Mazor M, Shoenfeld Y. Erdheim-Chester disease: a comprehensive review of the literature. Orphanet J Rare Dis. 2013;8:137. - PMC - PubMed
    1. Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, Wechsler B, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117:2778–2782. - PubMed
    1. Haroche J, Arnaud L, Amoura Z. Erdheim-Chester disease. Curr Opin Rheumatol. 2012;24:53–59. - PubMed
    1. Munoz J, Janku F, Cohen P, Kurzrock R. Erdheim-Chester disease: characteristics and management. Mayo Clin Proc. 2014;89:985–996. - PubMed
    1. Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood. 2013;121:1495–1500. - PubMed

LinkOut - more resources